Latest News in Pharma industry

1 day ago

Sanofi Acquires Alzheimer's Drug Developer Vigil Neuroscience for $600 Million to Advance Brain-Penetrating TREM2 Therapy

2 days ago

FDA Panel Backs First Treatment for High-Risk Smoldering Multiple Myeloma

3 days ago

Persist AI Raises $12M and Launches Cloud Lab Platform to Transform Pharmaceutical Formulation Speed

3 days ago

AstraZeneca's Breakthrough Asthma Treatment Challenges 50 Years of Standard Care

4 days ago

Novo Nordisk's Leadership Crisis - Strategic Implications of Jørgensen's Surprise Exit

7 days ago

Takeda's Narcolepsy Drug Shows Breakthrough Results in Restoring Normal Wakefulness for Patients

7 days ago

Pathos AI Raises $365 Million to Build Largest Multimodal Foundation Model for Cancer Drug Development

8 days ago

In a First for a Rare Cancer, Merck Secures FDA Nod for WELIREG — But Market Access and Safety Risks Loom Large

9 days ago

UnitedHealth Shares Plunge as Former CEO Hemsley Returns Following Witty's Abrupt Exit

15 days ago

Amgen Wins UK Approval for First Targeted Thyroid Eye Disease Treatment as Pressure Mounts from Cheaper Rivals

18 days ago

Early Trial Shows REC-4881 Reduces Polyp Burden by 43 Percent in Rare Genetic Cancer Disorder

19 days ago

Gene Therapy Market Shaken as Vertex Abandons AAV Technology Amid Safety Concerns and Regulatory Upheaval

20 days ago

Pykus Therapeutics' Novel Retinal Sealant Shows 91% Success Rate in Early Trials, Eliminating Need for Face-Down Recovery

22 days ago

Semaglutide Shows Strong Results in Major Liver Disease Trial, FDA Review Now Underway

23 days ago

Semaglutide Safety Concerns Mount as CDC Links Popular Weight Loss Drugs to Over 24,000 Emergency Room Visits

24 days ago

German Pharma Giant Merck Acquires SpringWorks for $3.9 Billion in Rare Disease Market Push

26 days ago

Pfizer's Sasanlimab-BCG Combination Shows 32% Reduction in Bladder Cancer Recurrence in Landmark Trial

29 days ago

Brensocatib Shows Statistically Significant Results in Phase 3 ASPEN Trial for Bronchiectasis According to NEJM Publication

29 days ago

Corcept's Novel Cortisol Blocker Extends Survival in Advanced Ovarian Cancer Trial

30 days ago

Swiss Pharma Giant Roche Commits $50 Billion to Build US Manufacturing Empire, Creating 12,000 Jobs

36 days ago

Zenas BioPharma Faces Lawsuit Over Allegedly Misleading IPO Financial Disclosures

38 days ago

Trump Administration Launches National Security Tariff Probes Targeting Semiconductor and Pharmaceutical Imports

41 days ago

Amgen Reports First Survival Benefit in Global Phase 3 Trial for Relapsed Small Cell Lung Cancer

42 days ago

FDA Begins Phasing Out Animal Testing for Drug Safety Using AI Models and Human Organoids

43 days ago

Trump Announces Sweeping Tariffs on Imported Pharmaceuticals Triggering Market Selloff and Industry Backlash

43 days ago

Ireland Emerges as Europe's Most Vulnerable Economy in US-EU Tariff War

45 days ago

DHL Commits €2 Billion to Expand Global Healthcare Logistics Network by 2030

45 days ago

Genetic Test Validated to Predict Long-Term Side Effects of Radiation in Prostate Cancer Patients

49 days ago

BeiGene Retreats from Anti-TIGIT Bet, Exposing Industry-Wide Fault Lines in Immuno-Oncology

50 days ago

Why Genentech's 'Disappointing' MS Trial Outcome Might Be Its Most Reassuring Result Yet

50 days ago

Pfizer Faces Shareholder Backlash as Proxy Firm Opposes CEO’s $33 Million Pay Amid Revenue and Stock Decline

52 days ago

Chinese AI Biotech Sector Faces Downturn as Another Startup Struggles

53 days ago

Lilly’s Lepodisiran Cuts Genetic Heart Risk Factor by 94 Percent in Phase 2 Trial with Effects Lasting 1.5 Years

55 days ago

VRON-0200 Shows Promising Immune Response and Safety in Early Human Trial for Chronic Hepatitis B

55 days ago

Kobayashi Pharmaceutical Replaces President and Board Amid Health Crisis and Investor Pressure

55 days ago

Betting Big on Obesity - Inside Novo Nordisk’s $3 Billion Weekly M&A Gamble to Reinvent Weight Loss Treatment

57 days ago

Moderna Stock Drops Amid US Decision to Cut $2.6 Billion Vaccine Funding to Gavi

62 days ago

AstraZeneca’s Eneboparatide Meets Phase 3 Goals in Hypoparathyroidism Trial with Full Data Pending

63 days ago

Sanofi Acquires Dren Bio’s DR-0201 for $1.9 Billion to Advance Autoimmune Therapies

63 days ago

BioCopy Secures €8M to Accelerate AI-Powered Cancer Drug Discovery

65 days ago

bioMérieux Secures FDA Clearance for VITEK COMPACT PRO, Advancing Rapid Microbial Diagnostics

65 days ago

Maxion Therapeutics Secures $72M Series A to Advance KnotBody Antibody Drugs for Autoimmune and Pain Treatment

65 days ago

Google Unveils TxGemma AI to Accelerate Drug Discovery with Open Models

68 days ago

ELAHERE Improves Survival in Platinum-Resistant Ovarian Cancer AbbVie Releases Final Phase 3 Data

69 days ago

Sanofi Adopts FDA-Approved Flu Strains for 2025-26 Season to Ensure Vaccine Readiness

71 days ago

Trump Confronts Irish Prime Minister Over US Trade Deficit and Pharma Industry Shift

72 days ago

Geron CEO John Scarlett Steps Down as Biotech Firm Shifts Focus to Commercial Growth

73 days ago

Novartis Expands Radiopharmaceutical Investments with $10 Billion Growth Target

74 days ago

Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Small Aortic Annulus Patients

75 days ago

Bristol Myers Squibb's Sotyktu Shows Strong Phase 3 Results in Psoriatic Arthritis Trial, Eyes Regulatory Approval